PRGO (Perrigo Co) 5-Year Yield-on-Cost %: 13.36 (As of Jul. 07, 2026) — 391% Above Median


PRGO Perrigo Co PLC PRGO
44 GF Score
Price $11.09
GF Value $24.97
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is Perrigo Co 5-Year Yield-on-Cost %?

Perrigo Co PRGO +0.64% 44 5-Year Yield-on-Cost % is 13.36 as of Jul. 07, 2026, which is 391% above its 10-year median of 2.72. GuruFocus rates PRGO with a GF Score™ of 44/100 and a GF Value™ of $24.97 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 518 Drug Manufacturers companies, Perrigo Co ranks better than 92.08% on this metric.

Perrigo Co's yield on cost for the quarter that ended in Mar. 2026 was 13.36.


The historical rank and industry rank for Perrigo Co's 5-Year Yield-on-Cost % or its related term are showing as below:

PRGO' s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 0.55   Med: 2.72   Max: 16.08
Current: 13.36


During the past 13 years, Perrigo Co's highest Yield on Cost was 16.08. The lowest was 0.55. And the median was 2.72.


PRGO's 5-Year Yield-on-Cost % is ranked better than
92.08% of 518 companies
in the Drug Manufacturers industry
Industry Median: 2.265 vs PRGO: 13.36

Perrigo Co  (NYSE:PRGO) 5-Year Yield-on-Cost % Explanation

Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.


Perrigo Co 5-Year Yield-on-Cost % Related Terms


PRGO vs XERS, PAHC, ALVO: 5-Year Yield-on-Cost % Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Perrigo Co's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Perrigo Co 5-Year Yield-on-Cost % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Perrigo Co's 5-Year Yield-on-Cost % distribution charts can be found below:

* The bar in red indicates where Perrigo Co's 5-Year Yield-on-Cost % falls into.


PRGO
44GF Score
Perrigo Co PLC PRGO
5-Year Yield-on-Cost % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Perrigo Co 5-Year Yield-on-Cost % Calculation

Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.

Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.

Therefore, Yield-on-Cost of Perrigo Co is calculated as

Yield-on-Cost=Dividend Yield %*(1+Dividend Growth Rate)^5
Frequently Asked Questions Learn more about 5-Year Yield-on-Cost % →
What does a 5-Year Yield-on-Cost % of 13.36 mean?
Perrigo Co (PRGO) has a 5-Year Yield-on-Cost % of 13.36 as of Jul. 07, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Perrigo Co and its competitors. This is 391% above median its historical median of 2.72. Over the past decade, Perrigo Co's 5-Year Yield-on-Cost % has ranged from 0.55 to 16.08. According to the industry distribution chart, Perrigo Co ranks #41 out of 518 companies in the Drug Manufacturers industry, placing it in the top 7.9%.
Is Perrigo Co's 5-Year Yield-on-Cost % too high?
Perrigo Co's current 5-Year Yield-on-Cost % of 13.36 is 391% above median its 10-year median of 2.72. Over the past 10 years, this metric has ranged from a low of 0.55 to a high of 16.08. The Drug Manufacturers industry median 5-Year Yield-on-Cost % is 2.27. Perrigo Co's value of 13.36 is 489.8% above this industry median. Based on the distribution chart, Perrigo Co ranks #41 out of 518 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Perrigo Co has a GF Score™ of 44/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Perrigo Co's 5-Year Yield-on-Cost % compare to XERS and PAHC?
According to the Drug Manufacturers industry distribution chart, Perrigo Co ranks #41 out of 518 companies for 5-Year Yield-on-Cost %. This places Perrigo Co in the top 8% of its industry — outperforming the majority of peers. The industry median 5-Year Yield-on-Cost % is 2.27. Perrigo Co's value of 13.36 is 489.8% above this benchmark. Historically, Perrigo Co's own 5-Year Yield-on-Cost % has ranged from 0.55 to 16.08 over the past decade. While the company's 10-year median is 2.72 vs. the industry median of 2.27, Perrigo Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a Drug Manufacturers company?
The median 5-Year Yield-on-Cost % among Drug Manufacturers companies is 2.27, based on 518 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Perrigo Co's current 5-Year Yield-on-Cost % of 13.36 is 489.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Perrigo Co and its competitors. For the Drug Manufacturers industry, the median 5-Year Yield-on-Cost % is 2.27 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Perrigo Co's current 5-Year Yield-on-Cost % is 13.36, which is 391% above median its own 10-year median of 2.72. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Perrigo Co stock overvalued right now?
Based on GuruFocus' analysis, Perrigo Co (PRGO) is currently considered Possible Value Trap. The stock's GF Value™ is $24.97, compared to a current price of $11.09 — trading 55.6% below its estimated fair value. The current 5-Year Yield-on-Cost % is 13.36, which is 391% above median its 10-year median of 2.72 and 489.8% above the Drug Manufacturers industry median of 2.27. Perrigo Co's overall GF Score™ is 44/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For Perrigo Co (PRGO), the current 5-Year Yield-on-Cost % is 13.36 as of Jul. 07, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Perrigo Co (PRGO) Overvalued in 2026?

Based on GuruFocus' analysis, Perrigo Co stock appears to be undervalued. The current stock price of $11.09 is trading 55.6% below its estimated GF Value™ of $24.97. GuruFocus considers Perrigo Co to be Possible Value Trap.

Key valuation signals for PRGO:

  • 5-Year Yield-on-Cost %: 13.36 (391% above median its 10-year median of 2.72)
  • GF Value™: $24.97 vs. price of $11.09 (55.6% below fair value)
  • GF Score™: 44/100 with 4 warning signs
  • Industry Position: 489.8% above the Drug Manufacturers median (#41 of 518)

No single metric tells the full story. See the PRGO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Perrigo Co Business Description

Address The Sharp Building, Hogan Place, Dublin, IRL, D02 TY74
Perrigo is one of the largest consumer health companies in the world. Since 2018, Perrigo has divested its animal health and generic pharmaceuticals businesses to solely focus on consumer self-care. In North America (two-thirds of total sales), the firm's product mix is anchored in private-label consumer health goods, which are sold to major retailers like Walmart, Amazon, Costco, and CVS. Perrigo also plays in Europe, Australia, and parts of Asia where it primarily generates revenue through its national brands, including Compeed, Solpadeine, Coldrex, and ellaOne.
44GF Score

Get the complete analysis for PRGO

5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$11.09
Price
$24.97
GF Value